Express Scripts says Amgen data opens door to patients
March 17, 2017 at 11:22 AM EDT
NEW YORK, March 17 (Reuters) - Express Scripts Holding Co Chief Medical Officer Dr. Steve Miller said on Friday that the data on heart drug Repatha from Amgen Inc was incrementally better and would change patient access to the drug.
